Royal Bank of Canada
BRTX icon

Royal Bank of Canada’s BioRestorative Therapies BRTX Stock Holding History

Royal Bank of Canada’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13
Closed – – 7380
2022
Q1 		$0 Buy
+13
New +$56 ﹤0.01% 7742

Other funds holding BRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Royal Bank of Canada's BRTX Position: Q2 2022 in Review

Royal Bank of Canada sold out of BioRestorative Therapies (BRTX) in Q2 2022, closing a stake of 13 shares.

Royal Bank of Canada first reported a position in BRTX in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 13 funds tracked by Wall St. Rank hold BRTX as of Q2 2022.

  • Royal Bank of Canada reported no remaining BioRestorative Therapies position as of Q2 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 13 BioRestorative Therapies shares in Q2 2022.
  • Royal Bank of Canada first reported a position in BioRestorative Therapies in Q1 2022 and held it in 1 quarter.
  • Royal Bank of Canada's BioRestorative Therapies position peaked at $0 in Q1 2022.
  • 13 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2022.

Based on Royal Bank of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.